TrademarkDir
KITE KONNECT
LIVE

Serial Number

87979871

Owner

Kite Pharma, Inc.

Attorney

Cynthia Smuzynska

First Use Date

Nov 22, 2017

Filing Date

Oct 20, 2016

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

KITE KONNECT Trademark

Serial Number: 87979871 • Registration: 5717953

KITE KONNECT is a trademark filed by Kite Pharma, Inc. on October 20, 2016. The trademark is classified under Class 44 (Medical Services), Class 45 (Legal & Security Services). The application is currently registered and active.

Owner Contact Info

Kite Pharma, Inc. (157 trademarks)

2400 Broadway

Entity Type: 99

Trademark Details

Filing Date

October 20, 2016

Registration Date

April 2, 2019

First Use Anywhere

November 22, 2017

First Use in Commerce

November 22, 2017

Published for Opposition

March 14, 2017

Goods & Services

Providing medical information; providing a web site featuring medical information; providing medical information, consultancy and advisory services; providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals

Providing patient advocate services in the field of the treatment of diseases and disorders

Filing History

TEAS CHANGE OF CORRESPONDENCE RECEIVED
Apr 14, 2026 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Apr 14, 2026 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Apr 14, 2026 REAP
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Jul 1, 2025 NA85
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Jul 1, 2025 C15A
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jun 30, 2025 APRE
TEAS SECTION 8 & 15 RECEIVED
Mar 5, 2025 E815
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Apr 2, 2024 REM1
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
May 12, 2020 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
May 12, 2020 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
May 12, 2020 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
May 12, 2020 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
May 12, 2020 COAR
REGISTERED-PRINCIPAL REGISTER
Apr 2, 2019 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Feb 27, 2019 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Feb 26, 2019 CNPR
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 8, 2019 EXRA
STATEMENT OF USE PROCESSING COMPLETE
Feb 7, 2019 SUPC
DIVISIONAL PROCESSING COMPLETE
Feb 7, 2019 DPCC
SOU EXTENSION 3 GRANTED
Feb 7, 2019 EX3G
RESPONSE TO ITU OFFICE ACTION ENTERED
Dec 26, 2018 IROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 26, 2018 TROA
ITU OFFICE ACTION ISSUED FOR DIVISIONAL REQUEST
Dec 4, 2018 INCD
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Nov 30, 2018 AITU
USE AMENDMENT FILED
Nov 8, 2018 IUAF
DIVISIONAL REQUEST RECEIVED
Nov 8, 2018 DRRR
SOU EXTENSION 3 FILED
Nov 8, 2018 EXT3
TEAS REQUEST TO DIVIDE RECEIVED
Nov 8, 2018 ERTD
SOU TEAS EXTENSION RECEIVED
Nov 8, 2018 EEXT
TEAS STATEMENT OF USE RECEIVED
Nov 8, 2018 EISU
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Oct 5, 2018 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Oct 5, 2018 REAP
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 20, 2018 EXRA
SOU EXTENSION 2 GRANTED
Mar 16, 2018 EX2G
SOU EXTENSION 2 FILED
Mar 16, 2018 EXT2
SOU TEAS EXTENSION RECEIVED
Mar 16, 2018 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 7, 2017 EXRA
SOU EXTENSION 1 GRANTED
Nov 3, 2017 EX1G
SOU EXTENSION 1 FILED
Nov 3, 2017 EXT1
SOU TEAS EXTENSION RECEIVED
Nov 3, 2017 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
May 9, 2017 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 14, 2017 NPUB
PUBLISHED FOR OPPOSITION
Mar 14, 2017 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 22, 2017 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 1, 2017 CNSA
ASSIGNED TO EXAMINER
Jan 30, 2017 DOCK
NOTICE OF PSEUDO MARK E-MAILED
Oct 27, 2016 MPMK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 26, 2016 NWOS
NEW APPLICATION ENTERED
Oct 24, 2016 NWAP

Related Trademarks

More from this Owner

KITE DUOCORE

KITE DUOCORE

MMOREINFORMED

MMOREINFORMED

FOCUSED ON THE CURE

FOCUSED ON THE CURE

MMOREINFORMED

MMOREINFORMED

FOCUSED ON THE CURE

FOCUSED ON THE CURE

KNOWMMORE

KNOWMMORE